Application
IHC analysis of rat dorsal root ganglion using Nav1.7 antibody (red) and Parvalbumin antibody (green). C. Confocal merge of A and B.Application
ICC/IF analysis of rat DRG primary culture using Nav1.7 antibody at a dilution of 1:200.Application
WB analysis of DRG lysates using Nav1.7 antibody at a dilution of 1:200 in the (1) absence or (2) presence of blocking peptide.Application
WB analysis of ND7/23 cell lysate (lanes 1 and 3) and rat brain membranes (lanes 2 and 4) using Nav1.7 antibody at a dilution of 1:200 in the absence (lens 1 and 2) or presence (lens 3 and 4) of blocking peptide.| Product Name | NAV1.7 antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Product description | Rabbit Polyclonal antibody to NAV1.7voltage-dependent sodium channel alpha subunit which may be the major channel in the peripheral nervous system [RGD, Feb 2006] |
| Immunogen | Peptide (C)EFTSIGRSR IMGLSE, corresponding to amino acid residues 446-460 of rat NaV1.7 (Accession O08562). Intracellular loop between domains I and II. |
| Clonality | Polyclonal |
|---|---|
| Host Species | Rabbit |
| Tested Applications | ICC/IFIHCWB |
| ICC/IF:1:200~1:500 IHC:1:50~1:200 WB:1:500~1:2000 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|
| Species Reactivity | HumanMouseRat |
| Concentration | 1mg/ml |
| Purification | Affinity purified |
| Gene Synonyms | Nav1.7 Scn2a sodium channel voltage-gated type IX alpha Scn9a PN1 |
|---|---|
| Target | NAV1.7 |
Application
IHC analysis of rat dorsal root ganglion using Nav1.7 antibody (red) and Parvalbumin antibody (green). C. Confocal merge of A and B.
Application
ICC/IF analysis of rat DRG primary culture using Nav1.7 antibody at a dilution of 1:200.
Application
WB analysis of DRG lysates using Nav1.7 antibody at a dilution of 1:200 in the (1) absence or (2) presence of blocking peptide.
Application
WB analysis of ND7/23 cell lysate (lanes 1 and 3) and rat brain membranes (lanes 2 and 4) using Nav1.7 antibody at a dilution of 1:200 in the absence (lens 1 and 2) or presence (lens 3 and 4) of blocking peptide.| Application Notes | ICC/IF:1:200~1:500 IHC:1:50~1:200 WB:1:500~1:2000 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | Keep as concentrated solution. Aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Phosphate buffered saline (PBS), pH 7.4, 1% BSA and 0.05% NaN3. |
